Back to Search Start Over

Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease.

Authors :
Abdullahi, Auwal
Wong, Thomson WL
Ng, Shamay SM
Source :
Ageing Research Reviews. Feb2024, Vol. 94, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

Alzheimer's disease (AD) is a very disabling disease. Pathologically, it is characterized by the presence of amyloid plaques and neurofibrillary tangles in the brain that results in neurodegeneration. Its clinical manifestations include progressive memory impairment, language decline and difficulty in carrying out activities of daily living (ADL). The disease is managed using interventions such as pharmacological interventions and aerobic exercise. Use of aerobic exercise has shown some promises in reducing the risk of developing AD, and improving cognitive function and the ability to carry out both basic and instrumental ADL. Although, the mechanisms through which aerobic exercise improves AD are poorly understood, improvement in vascular function, brain glucose metabolism and cardiorespiratory fitness, increase in antioxidant capacity and haemoglobin level, amelioration of immune-related and inflammatory responses, modulation of concentration of circulating Neurotrophins and peptides and decrease in concentration of tau protein and cortisol level among others seem to be the possible mechanisms. Therefore, understanding these mechanisms is important to help characterize the dose and the nature of the aerobic exercise to be given. In addition, they may also help in finding ways to optimize other interventions such as the pharmacological interventions. However, more quality studies are needed to verify the mechanisms. • Alzheimer's disease (AD) seriously affects cognitive and physical function. • A promising intervention in patients with AD is aerobic exercise. • The exercise modulates disease biomarkers, and improves brain glucose metabolism and vascular function. • It also increases antioxidant capacity and levels of brain-derived neurotrophic factor. • Modulation of those biomarkers helps to slow down progression of the disease. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15681637
Volume :
94
Database :
Academic Search Index
Journal :
Ageing Research Reviews
Publication Type :
Academic Journal
Accession number :
175300585
Full Text :
https://doi.org/10.1016/j.arr.2024.102202